
Dong-A ST profit soars as Stelara biosimilar launch drives Q1 gains at Dong-A Socio
Dong-A Socio Holdings posted a 31 percent jump in first-quarter operating profit, powered by an 854 percent surge at drugmaker Dong-A ST and a 556 percent spike at CDMO affiliate STgen Bio following the launch of a Stelara biosimilar. The Korean …